arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

CUMBERLAND PHARMACEUTICALS INC

CPIX
$7.83 ▲ +0.19 (+2.49%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
67 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
31
Health
Poor
Bearish
auto_awesome

Analytical Summary

CUMBERLAND PHARMACEUTICALS INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $117.1M
Dividend Yield
Revenue Growth -22.0%
Op. Margin -34.3%
ROIC -11.4%
FCF / Share $0.03
Trailing P/E
Price / Book 5.4x
FCF Yield 0.3%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$9.13M
↓ -22.0%
Net Income Profit after all expenses
$-3.29M
↓ -133.0%
Operating Margin Operating profit as % of sales
-34.3%
↓ -241.9% 19th
FCF / Share Free cash flow per share
$0.03
↓ -90.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
34
Returns
33
Financial Health
35
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters